Delivery Order SPE2DR25D1100-SPE2DR26FCS1D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,459.25 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed price delivery order, with an ultimate completion date of September 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement process. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $19,227.50 and a completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $7,691.00 with a firm fixed price structure. This non-competitive delivery order, issued on November 12, 2025, is scheduled for completion by December 4, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a $36,490 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gel-One 30 mg/3 mL syringes under a firm fixed-price contract. The order is expected to be completed by October 17, 2025, with performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 ml syringes on October 20, 2025. This is a firm fixed price, non-set-aside contract with performance expected to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 22, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS1DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide. The contractor's contract portfolio demonstrates extensive experience fulfilling federal procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 11/30/25 |